| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.91B | 31.51B | 24.03B | 18.87B | 15.25B | 8.89B |
| Gross Profit | 14.06B | 18.05B | 13.78B | 10.20B | 8.03B | 4.30B |
| EBITDA | 8.14B | 11.10B | 8.10B | 6.20B | 4.62B | 2.00B |
| Net Income | 4.85B | 7.67B | 5.07B | 3.85B | 3.00B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 29.35B | 39.12B | 29.53B | 25.83B | 19.61B | 16.35B |
| Cash, Cash Equivalents and Short-Term Investments | 13.49B | 16.32B | 12.65B | 9.45B | 6.64B | 4.72B |
| Total Debt | 3.29B | 2.82B | 2.91B | 2.13B | 1.16B | 1.28B |
| Total Liabilities | 8.24B | 11.28B | 8.10B | 8.09B | 5.27B | 4.48B |
| Stockholders Equity | 21.11B | 27.84B | 21.43B | 17.74B | 14.33B | 11.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.56B | 4.27B | 2.90B | 2.62B | 1.01B |
| Operating Cash Flow | 0.00 | 8.10B | 6.00B | 3.28B | 3.11B | 1.41B |
| Investing Cash Flow | 0.00 | -3.94B | -1.88B | -194.81M | -788.10M | -2.10B |
| Financing Cash Flow | 0.00 | -2.48B | -700.47M | -213.34M | -773.99M | 832.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥349.88B | 25.22 | 25.32% | 2.30% | 31.13% | 51.29% | |
79 Outperform | ¥1.07T | 21.67 | 11.99% | 0.65% | 8.38% | 8.43% | |
75 Outperform | ¥354.62B | 13.22 | ― | 2.04% | -8.82% | 18.33% | |
74 Outperform | ¥821.13B | 20.14 | 4.03% | 2.25% | 5.36% | -24.06% | |
70 Outperform | ¥564.17B | 16.37 | 7.44% | 1.76% | 3.97% | 29.53% | |
70 Outperform | ¥1.03T | 17.62 | 11.14% | 1.46% | 4.02% | 13.81% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |